RxDoctor Payments Data

John Osei Tutu, MD

Psychiatry · Bronx, NYNPI 1912042169

Payments from drug & device makers

$2,104in general payments, 2019–2025

Across 103 payments — averaging $20.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$384
  • Lundbeck LLC$353
  • Johnson & Johnson$347
  • Otsuka America Pharmaceutical, Inc.$272
  • Teva Pharmaceuticals USA, Inc.$252
  • E.r. Squibb & Sons, L.L.C.$191
  • plus $305 from 5 others

What the payments were for

  • Food & beverage$2,05798%
  • Education$472%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,104 in reported general payments places this provider in the 80th percentile of 3,713 psychiatry providers in New York.

See all psychiatry providers in New York

Medicare billing

Part B allowed, 2024
$34,055
Medicare patients
70
Services billed
436

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate86$205,775
Abilify MaintenaAripiprazole23$50,345
Risperdal ConstaRisperidone Microspheres19$43,610
VivitrolNaltrexone Microspheres11$18,151
Clozapine225$15,993
SuboxoneBuprenorphine Hcl/Naloxone Hcl11$7,504
Aripiprazole121$5,858
Fluphenazine Hcl29$3,320
Haloperidol Decanoate99$2,277
Divalproex Sodium ErDivalproex Sodium71$1,963
Olanzapine74$1,600
Duloxetine Hcl64$1,508
Divalproex Sodium97$1,505
Bupropion XlBupropion Hcl95$1,344
Benztropine Mesylate187$1,170

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Risperdal Consta$347$249,385105 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$272$50,34523 claims
Alkermes, Inc.Vivitrol$384$18,15111 claims
Indivior Inc.Suboxone$15$7,50411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,713 psychiatry providers in New York.

Other psychiatry in Bronx

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →